The DEFINE study: a bright future for CETP inhibitors?

Author： Katsiki Niki Athyros Vasilios G Mikhailidis Dimitri P

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.20, Iss.3, 2011-03, pp. : 311-314

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Current Status of CETP Inhibitors in the Treatment of Hyperlipidemia: An Update

Current Clinical Pharmacology, Vol. 7, Iss. 2, 2012-01 ,pp. : 102-110

Bentham Science Publishers

Access to resources Recommend Favorite

Cholesteryl Ester Transfer Protein (CETP) Inhibitors

Current Topics in Medicinal Chemistry, Vol. 9, Iss. 5, 2009-04 ,pp. : 419-427

Bentham Science Publishers

Access to resources Recommend Favorite

Molecular Docking and Pharmacophore Modeling Studies of Fluorinated Benzamides as Potential CETP Inhibitors

Medicinal Chemistry, Vol. 13, Iss. 3, 2017-04 ,pp. : 239-253

Bentham Science Publishers

Access to resources Recommend Favorite

JTT-705: is there still future for a CETP inhibitor after torcetrapib?

By Rennings Alexander JM Stalenhoef Anton FH

Expert Opinion on Investigational Drugs, Vol. 17, Iss. 10, 2008-10 ,pp. : 1589-1597

Informa Healthcare

Access to resources Recommend Favorite

Emerging options in the treatment of dyslipidemias: a bright future?

By Florentin Matilda Liberopoulos Evangelos N Mikhailidis Dimitri P Elisaf Moses S

Expert Opinion on Emerging Drugs, Vol. 16, Iss. 2, 2011-06 ,pp. : 247-270

Informa Healthcare

Access to resources Recommend Favorite